Keyphrases
Adult Patients
100%
Spinal muscular Atrophy Type 2
100%
Spinal muscular Atrophy Type III
100%
Nusinersen
100%
Respiratory Function
40%
Annual Rate of Change
40%
Clinical Trials
20%
Tel Aviv
20%
Treatment Effect
20%
Pediatric Patients
20%
Medical Center
20%
Treatment Safety
20%
Large Cohort
20%
Muscle Strength
20%
Neurological Impairment
20%
Motor Function
20%
Baseline Measurements
20%
Medical Research Council
20%
Post-dural Puncture Headache
20%
Spinal muscular Atrophy
20%
Hammersmith
20%
SMA3
20%
Muscle Stability
20%
Medicine and Dentistry
Nusinersen
100%
Spinal Muscular Atrophy Type 2
100%
Kugelberg Welander Disease
100%
Side Effect
40%
Respiratory Physiology
40%
Treatment Effect
20%
Pediatrics Patient
20%
Stereotypic Movement Disorder
20%
Cohort Analysis
20%
Clinical Trial
20%
Medical Research
20%
Motor Performance
20%
Muscle Strength
20%
Post-Dural-Puncture Headache
20%
Spinal Muscular Atrophy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nusinersen
100%
Kugelberg Welander Disease
100%
Spinal Muscular Atrophy Type 2
100%
Side Effect
40%
Clinical Trial
20%
Cohort Study
20%
Motor Dysfunction
20%
Postdural Puncture Headache
20%
Spinal Muscular Atrophy
20%